Navigation Links
Particle Sciences Completes Development of First Product Incorporating its Unique Surface Modification System
Date:2/24/2009

BETHLEHEM, Pa., Feb. 24 /PRNewswire/ -- Particle Sciences Inc. today announced the development of a unique film-forming system with applications ranging from tissue hydration to the passivation of medical device surfaces. "The backbone of the system is a series of patent-pending polymers that allow Particle Sciences to 'dial in' the desired contact angle," says Andrew Loxley, PS' Director of New Technologies.

Particle Sciences has already used the system to develop an ocular formulation for one of its clients. Early clinical results are very promising but are still embargoed. "In this application, we were able to achieve substantial improvement over existing products in terms of degree and duration of activity using this newly developed approach," says Robert Lee, PS' VP Pharmaceutical Development.

Dr. Lee adds that "This technology adds to the broad array of approaches Particle Sciences has to address our clients' needs. As formulations become increasingly challenging, Particle Sciences has positioned itself well with the development and acquisition of various technologies and capabilities focused on drug delivery."

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. For more information on Particle Sciences, visit www.particlesciences.com.

    Contact:
    Maureen Cochran
    '/>"/>
SOURCE Particle Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
2. Anthrax vaccine produces immunity with nanoparticles, not needles
3. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
4. New DNA-based technique for assembly of nano- and micro-sized particles
5. New nanoparticle vaccine is more effective but less expensive
6. Anthrax vaccine produces immunity with nanoparticles, not needles
7. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
8. Researchers outline structure of largest nonvirus particle ever crystallized
9. DNA technique yields 3-D crystalline organization of nanoparticles
10. Strengthening fluids with nanoparticles
11. 2-faced particles act like tiny submarines

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...RNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: ...wing letter to its shareholders, discussing the Co... Biopharmaceuticals Holdings, Inc. (CHBP), an inte...ple,s Republic of China. The merger gives NeoStem ...utical Co. Ltd., CHBP,s primary operating subsidia...
(Date:11/19/2009)...ASIK surgeons and recognized refractive and catara...s made brought their fellow surgeons up-to-date on...ery, cataract surgery, and ophthalmology in genera...hthalmology (AAO) annual meeting in San Francisco,...uber, Dr. David Huang, MD, Dr. Randy Epstein, Dr. ...
(Date:11/18/2009)...titute of Standards and Technology (NIST) has demo...or detecting and measuring elusive hazards such as...ge in food or pesticides distributed in soil by wi...e than conventional techniques for detecting trace...lecules, having distinct electrically positive and...
(Date:11/18/2009)...nce in data analysis combined with Bio-Rad,s B...d curricula provide state-of-the-art solutions to ...ov. 18 Vernier Software & Tech...es, sensors, and software and Bio-Rad Laboratories...or of life science research and clinical diagnosti...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Prototype NIST method detects and measures elusive hazards 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2
...(NYSE: STE ) today announced financial results fo...0, 2008. Fiscal 2009 second quarter revenues,incre...llion in the second,quarter of fiscal 2008, driven...Fiscal 2009 second quarter net income was $28.8 mi...et income of $16.0 million, or $0.25 per,diluted s...
..., M.D., a world renowned urologic oncologist, disc... following an OR Live Webcast. His proprietary tec...ble for sexual function and continence. To date, D...e surgeries and the results are quite pleasing for..., NY (PRWEB) October 30, 2008 -- Dr. David Samadi,...
...nc.,(NYSE: BMR ), a real estate investment trust ...ce industry, today announced financial results for...ghlights:, -- Quarterly total revenues increased ...he third quarter 2007, -- Completed delivery of t... and office facility at our Towne Centre Drive cam...
Other Biology Technology:STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results 2STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results 3STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results 4STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results 5STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results 6STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results 7STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results 8STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results 9STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results 10STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results 11Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 2Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 3Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 4BioMed Realty Trust Reports Third Quarter 2008 Financial Results 2BioMed Realty Trust Reports Third Quarter 2008 Financial Results 3BioMed Realty Trust Reports Third Quarter 2008 Financial Results 4BioMed Realty Trust Reports Third Quarter 2008 Financial Results 5BioMed Realty Trust Reports Third Quarter 2008 Financial Results 6BioMed Realty Trust Reports Third Quarter 2008 Financial Results 7BioMed Realty Trust Reports Third Quarter 2008 Financial Results 8BioMed Realty Trust Reports Third Quarter 2008 Financial Results 9BioMed Realty Trust Reports Third Quarter 2008 Financial Results 10BioMed Realty Trust Reports Third Quarter 2008 Financial Results 11BioMed Realty Trust Reports Third Quarter 2008 Financial Results 12BioMed Realty Trust Reports Third Quarter 2008 Financial Results 13
(Date:11/19/2009)...ortant crop in many countries of the world. It is ...d industrial materials. It also is considered an e...molecular evolution, and genome architecture. The ...collection used the first description of the B73 m...uestions in genetics and plant biology. The ten pa...
(Date:11/19/2009)...rvey of genetic diversity in maize, also known as ...eveloped a gene map that should pave the way to si...source of food, fuel, animal feed and fiber around...e map known as a haplotype map, charts genetic div...nbred lines of maize. The research team, led by U....
(Date:11/19/2009)...., Nov. 19, 2009 -- Sustainable farming, initially...ations, may also play a role in maintaining a heal...tment of Energy,s Oak Ridge and Los Alamos nationa...xploring the large potential of the earth,s soils ...new land-use practices could greatly reduce U.S. c...
Breaking Biology News(10 mins):PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Award Winning Medical Technology From Germany 5432 1Award Winning Medical Technology From Germany 5432 2Award Winning Medical Technology From Germany 5432 3Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference 5430 1Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference 5430 2MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples 5428 1MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples 5428 2
...ailable in German . , A few days before the Ge...Stem Cell Act, the Deutsche Forschungsgemeinschaft...its stance on amending current legislation. The cu...y impedes German stem cell research, explained DFG...e participating in a live chat session on the DFG ...
...il 9. . . Two new studies presented at the Experi...natural dietary supplement made from citrus may he...lucose numbers after a meal and their LDL-choleste...rgize Incs Scientific Director, said, ,Our scient...that Diabetinol improves blood glucose numbers. Th...
... obstacle when it comes to starting a business. Th... Alchemist Empire, Inc., who invented a trading ca...o students in a fun, unusual way. , At the 235th ...in New Orleans, Samar will present his inventive c...box, this precocious CEO hopes to secure $500,000 ...
Other Biology News:Qualifying date rule hinders German stem cell research 2Qualifying date rule hinders German stem cell research 3People with diabetes may have all natural citrus supplement 2People with diabetes may have all natural citrus supplement 314-year-old CEO makes chemistry a game with 'Elementeo' 2
Anti-Human JAM-1 Monoclonal Antibody, Unconjugated, Clone M.Ab.F11 from Cell Sciences
Goat Anti-Human / Mouse / Rat AMPK beta 1 Polyclonal Antibody, Unconjugated from R&D Systems
DHFR-1 FP-1 Forward Sequencing Primer from EPICENTRE Biotechnologies
Rat Anti-Mouse Laminin B2 gamma 1 Monoclonal Antibody, Unconjugated, Clone SPM277 from ABR-Affinity BioReagents
Biology Products: